Peptide/MHC tetramer-based sorting of CD8 T cells to a Leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire

Cancer Immunology Research

Volumn 3, Issue 3, 2015, Pages 228-235

  Hunsucker, Sally A ^a   McGary, Colleen S ^a   Vincent, Benjamin G ^a   Enyenihi, Atim A ^b   Waugh, Jennifer P ^c   McKinnon, Karen P ^a   Bixby, Lisa M ^a   Ropp, Patricia A ^a   Coghill, James M ^a,c   Wood, William A ^a,c   Gabriel, Don A ^a,c   Sarantopoulos, Stefanie ^a,c   Shea, Thomas C ^a,c   Serody, Jonathan S ^a,c   Alatrash, Gheath ^d   Rodriguez Cruz, Tania ^d   Lizee, Gregory ^d   Buntzman, Adam S ^e   Frelinger, Jeffrey A ^e   Glish, Gary L ^b   Armistead, Paul M ^a,c   more..

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LEUKEMIA ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TETRAMER; UNC CDK4 1; UNCLASSIFIED DRUG; HLA A2 ANTIGEN; HLA-A*02:01 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE; TUMOR ANTIGEN;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPITOPE MAPPING; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; MALE; IMMUNOLOGY; LEUKEMIA; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION; U-937 CELL LINE;

ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A2 ANTIGEN; HUMANS; LEUKEMIA; MALE; MIDDLE AGED; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; U937 CELLS;

EID: 84961922850     PISSN: 23266066     EISSN: 23266074     Source Type: Journal    
DOI: 10.1158/2326-6066.CIR-14-0001     Document Type: Article

References (25)

1. + T cells can mediate antileukemic activity and persist in post-transplant patients. Sci Transl Med 2013;5:174ra27.
2. Greiner J, Schmitt A, Giannopoulos K, Rojewski MT, Gotz M, Funk I, et al. High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma. Haematologica 2010;95:1191-7.
3. Meij P, Jedema I, van der Hoorn MA, Bongaerts R, Cox L, Wafelman AR, et al. Generation and administration of HA-1-specificT-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study. Haematologica 2012;97:1205-8.
4. Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE, et al. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000;6:1018-23.
5. Wang GC, Dash P, McCullers JA, Doherty PC, Thomas PG. T cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection. Sci Transl Med 2012;4: 128ra42.
6. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, et al. Characterization of peptides bound to the class IMHC molecule HLA-A2.1 by mass spectrometry. Science 1992;255:1261-3.
7. + T cells. Nat Protoc 2014;9: 950-66.
8. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003;281:65-78.
9. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science 1996;274:94-6.
10. Armistead PM, Liang S, Li H, Lu S, Van Bergen CA, Alatrash G, et al. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data. PLoS One 2011;6:e23217.
11. ∗0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia. Clin Cancer Res 2013;19:247-57.
12. + T cells and delay diabetes in nonobese diabetic mice. J Immunol 2010;184:4196-204.
13. Volpe JM, Cowell LG, Kepler TB. SoDA: implementation of a 3D alignment algorithm for inference of antigen receptor recombinations. Bioinformatics 2006;22:438-44.
14. Wang C, Sanders CM, Yang Q, Schroeder HW Jr, Wang E, Babrzadeh F, et al. High-throughput sequencing reveals a complex pattern of dynamic interrelati on ships among human T cell subsets. Proc Natl Acad Sci U S A 2010;107:1518-23.
15. Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, et al. IMGT, the international ImMunoGeneTics information system. Nuc Acids Res 2009;37 (Database issue):D1006-12.
16. Smith TF, Waterman MS. Identification of common molecular subsequences. J Mol Biol 1981;147:195-7.
17. Karp JE, Smith BD, Resar LS, Greer JM, Blackford A, Zhao M, et al. Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias. Blood 2011;117:3302-10.
18. Lin TS, Ruppert AS, Johnson AJ, Fischer B, Heerema NA, Andritsos LA, et al. Phase II study of flavopiridol in relapsed chronic lymphocytic leukemia demonstrating high response rates in genetically high-risk disease. J Clin Oncol 2009;27:6012-8.
19. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009;9:153-66.
20. Krell PF, Reuther S, Fischer U, Keller T, Weber S, Gombert M, et al. Nextgeneration-sequencing-spectratyping reveals public T-cell receptor repertoires in pediatric very severe aplastic anemia and identifies a beta chain CDR3 sequence associated with hepatitis-induced pathogenesis. Haematologica 2013;98:1388-96.
21. Liu C, He M, Rooney B, Kepler TB, Chao NJ. Longitudinal analysis of T-cell receptor variable beta chain repertoire in patients with acute graft-versushost disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2006;12:335-45.
22. van Heijst JW, Ceberio I, Lipuma LB, Samilo DW, Wasilewski GD, Gonzales AM, et al. Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat Med 2013;19:372-7.
23. Engels B, Engelhard VH, Sidney J, Sette A, Binder DC, Liu RB, et al. Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity. Cancer Cell 2013;23:516-26.
24. Han A, Glanville J, Hansmann L, Davis MM. Linking T-cell receptor sequence to functional phenotype at the single-cell level. Nat Biotechnol 2014;32:684-92.
25. Kim SM, Bhonsle L, Besgen P, Nickel J, Backes A, Held K, et al. Analysis of the paired TCR alpha- and beta-chains of single human T cells. PLoS One 2012;7:e37338.